![]() |
|
|||||||||
|
|
||||||||||
|
|
Lead optimization is the process by which the chemical structure of a viable drug lead is modified in an iterative way to generate more active and/or more selective compounds.
Southwest Research Institute (SwRI) pharmaceutical industry-trained scientists offer their wide-ranging drug discovery experiences to assist clients' lead optimization needs. SwRI regularly uses an Accelrys Modeling system with a new Discovery Studio® to carry out structure-based compound design and QSAR studies. Syntheses of a wide variety of structural types have been completed in the Synthesis and Process Chemistry Section, meeting clients' new materials needs.
For more information about our medicinal chemistry/lead optimization capabilities, or how you can contract with SwRI, please contact Stanton McHardy, Ph.D., at smchardy@swri.org or (210) 522-2669.
|
|
||||||||
|
| Microencapsulation and Nanomaterials Department | Chemistry & Chemical Engineering Division | SwRI Home | |
||||||||||
|
Southwest Research Institute® (SwRI®), headquartered in San Antonio, Texas, is a multidisciplinary, independent, nonprofit, applied engineering and physical sciences research and development organization with 11 technical divisions. |
||||||||||
|
February 06, 2012 |
||||||||||